Trial Profile
STRategies in Early Arthritis Management.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2011
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Hydroxychloroquine; Methotrexate; Prednisone; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms STREAM
- 13 Dec 2011 Primary endpoint 'Radiographic-outcomes' has not been met.
- 13 Dec 2011 Status changed from active, no longer recruiting to completed.
- 09 Dec 2009 New source identified and integrated (Netherlands Trials Register, NTR144).